RetractedArticleOncology reports2018

Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathway.

Dan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.